Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures.
Paiva, J A
Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures. [electronic resource] - International journal of antimicrobial agents Oct 2017 - 529-535 p. digital
Publication Type: Journal Article
1872-7913
10.1016/j.ijantimicag.2017.05.017 doi
Aged
Amphotericin B--therapeutic use
Antifungal Agents--therapeutic use
Aspergillus--drug effects
Clinical Decision-Making
Critical Illness
Delayed Diagnosis--mortality
Drug Therapy, Combination
Echinocandins--therapeutic use
Female
Fungal Proteins--therapeutic use
Humans
Intensive Care Units
Invasive Pulmonary Aspergillosis--diagnosis
Male
Middle Aged
Prognosis
Respiratory System--microbiology
Treatment Outcome
Voriconazole--therapeutic use
Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures. [electronic resource] - International journal of antimicrobial agents Oct 2017 - 529-535 p. digital
Publication Type: Journal Article
1872-7913
10.1016/j.ijantimicag.2017.05.017 doi
Aged
Amphotericin B--therapeutic use
Antifungal Agents--therapeutic use
Aspergillus--drug effects
Clinical Decision-Making
Critical Illness
Delayed Diagnosis--mortality
Drug Therapy, Combination
Echinocandins--therapeutic use
Female
Fungal Proteins--therapeutic use
Humans
Intensive Care Units
Invasive Pulmonary Aspergillosis--diagnosis
Male
Middle Aged
Prognosis
Respiratory System--microbiology
Treatment Outcome
Voriconazole--therapeutic use